Omnicell to Relocate Mobile Cart Manufacturing to Livermore, CA

MOUNTAIN VIEW, Calif., May 13 Omnicell, Inc.(Nasdaq: OMCL) a leading provider of system solutions to acute healthcarefacilities, today announced plans to relocate its mobile cart manufacturingfrom Elgin, S.C. to its existing Livermore, Calif. facility.

The consolidation of mobile cart manufacturing services in near proximityto other Omnicell manufacturing and development resources supports thestrategy to integrate medication management system technology with mobile carttechnology.

Omnicell completed its acquisition of the Elgin-based, Rioux Vision mobilecart business in December 2007. With the addition of mobile cart technology,Omnicell is positioned to deliver a closed-loop medication management,administration and dispensing system that greatly reduces the risk ofmedication errors and allows Omnicell hospital customers to boost staffefficiency and advance patient safety. Recently, Omnicell introduced itsSafetyMed(R) system, the first bedside point-of-care software integrated witha smart mobile cart.

Omnicell expects to incur one time charges of approximately $1.1 millionassociated with the move, of which approximately $0.3 million is expected tobe recorded in the quarter ending June 30, 2008, and the remainder is expectedto be recorded in the quarter ending September 30, 2008. Approximately 40positions at the Elgin S.C. facility will be affected by the move. Omnicellexpects on-going operational savings from the consolidation of approximately$1.3 million annually.

Forward Looking Statements To the extent any statements contained in thispress release deal with information that is not historical, these statementsare necessarily forward-looking. As such, they are subject to the occurrenceof events outside Omnicell's control and are subject to various risk factorsthat could cause actual results to differ materially from those expressed orimplied in any forward-looking statement. Factors that could cause orcontribute to such differences include, but are not limited to, risksassociated with the effect of the consolidation on Omnicell's financialresults, Omnicell's ability to successfully relocate and integrate, within theexpense estimates used, the manufacturing processes or employees intoOmnicell's existing processes, and to realize the intended savings resultingfrom such consolidation. Prospective investors are cautioned not to placeundue reliance on forward-looking statements.

About Omnicell

Omnicell, Inc. (Nasdaq: OMCL) is a leading provider of systems targetingpatient safety and operational efficiency in healthcare facilities. Since1992, Omnicell has worked to enhance patient safety and allow clinicians tospend more time with their patients.

Omnicell's medication-use product line includes solutions for the centralpharmacy, nursing unit, operating room, and patient bedside. Solutions rangefrom complete automation systems for the central pharmacy to nursing unit andbedside dispensing cabinet systems. From the point at which a medicationarrives at the receiving dock to the time it is administered, Omnicell systemsstore it, package it, bar code it, order it, issue it, and provide informationand controls on its use and reorder.

Our supply product lines provide a healthcare institution with fast,effective control of costs, capture of charges for payer reimbursement, andtimely reorder of supplies. Products range from high-security closed-cabinetsystems and software to open-shelf and combination solutions in the nursingunit, cath lab and operating room. For more information, visithttp://www.omnicell.com.

SOURCE Omnicell, Inc.